Herein, we identified seven robust prognostic markers (SIGLEC14, GHRHR, TAS2R1, CDKL1, ZSCAN10, TBX15, and CD101) that were independent factors significantly correlated with the TTR of the primary GBM samples (Fig. 6A). Here, CD101 is linked to glioblastoma.